CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer’s disease

Nicolas R. Barthélemy(Washington University in St. Louis), Suzanne E. Schindler(Washington University in St. Louis), Randall J. Bateman(Washington University in St. Louis), Chihiro Sato(Washington University in St. Louis), Erik Stomrud(Lund University), Anne M. Fagan(Washington University in St. Louis), Yingxin He(Washington University in St. Louis), Vitaliy Ovod(Washington University in St. Louis), Oskar Hansson(Eli Lilly (United States)), Gemma Salvadó(Lund University), Rachel L. Henson(Meharry Medical College), John C. Morris(Washington University in St. Louis), Shorena Janelidze(Lund University), Kanta Horie(Washington University in St. Louis), Brian A. Gordon(Mallinckrodt (United States)), Yan Li(Washington University in St. Louis), Tammie L.S. Benzinger(Washington University in St. Louis), Chengjie Xiong(Guangzhou Institutes of Biomedicine and Health), Benjamin Saef(Washington University in St. Louis)
Nature Aging
March 13, 2023
Cited by 150


Related Papers